Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 1613 1615 1621 1674 3783
This examiner grants 28% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18408546 | THERAPEUTIC AGENTS AND THEIR USE FOR TREATING CHRONIC WOUNDS | Non-Final OA | President and Fellows of Harvard College |
| 17904553 | CROSSLINKED POLY(LACTIDE-CO-GLYCOLIDE) (PLGA)-DIMETHACRYLATE COATINGS AND METHODS OF USE | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 17762130 | KIT, SYSTEM AND METHOD FOR PREPARING AND USE OF A PERIOXIDE-CONTAINING COMPOSITION | Final Rejection | KONINKLIJKE PHILIPS N.V. |
| 18248021 | NANOMATERIAL AND METHODS OF USE THEREOF | Final Rejection | UNIVERSITY OF CONNECTICUT |
| 18099810 | DELIVERY DEVICES AND METHODS FOR MAKING THE SAME | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF MICHIGAN |
| 17789262 | OCTENIDINE SALT ANTIMICROBIAL MEDICAL ARTICLES | Non-Final OA | Solventum Intellectual Properties Company |
| 17599440 | DYEING PROCESS USING PEROXYGENATED SALTS AND A SUBSTRATE COMPRISING OXIDATION DYES | Final Rejection | L'OREAL |
| 17796925 | METHODS FOR MICROWAVE SYNTHESIS OF DEGRADABLE POLYMERS FOR DRUG DELIVERY | Final Rejection | The General Hospital Corporation |
| 17991937 | Ionic Polymers For Medical Device Applications | Non-Final OA | Becton, Dickinson and Company |
| 18017583 | COMPOSITION FOR PREVENTING ADHESION | Final Rejection | The University of Tokyo |
| 18177659 | SILK FIBROIN COMPOSITE MATERIAL WITH INCREASED CONTENT OF BETA-SHEET AND METHOD FOR PREPARING THE SAME | Final Rejection | Industry-Academic Cooperation Foundation, Yonsei University |
| 18999039 | Surfactant Formulations for Inhalation | Final Rejection | Merz Pharmaceuticals, LLC |
| 18018275 | ANTIMICROBIAL SILK NANOPARTICLES AND METHODS FOR MAKING AND USING THE SAME | Final Rejection | University of Georgia Research Foundation, Inc. |
| 18016095 | ANTI-MICROBIAL MEDICAL GRADE POLYMER SUBSTRATES WITH ANTI-FUNGAL AND ANTI-BACTERIAL PROPERTIES | Final Rejection | University of Georgia Research Foundation, Inc. |
| 17560819 | METHOD FOR MANUFACTURING ORALLY DISINTEGRATING TABLET, AND ORALLY DISINTEGRATING TABLET | Non-Final OA | SAWAI PHARMACEUTICAL Co., Ltd. |
| 18044233 | PHARMACEUTICAL COMPOSITION COMPRISING CHLOROQUINE AND USES THEREOF | Non-Final OA | Philip Morris Products S.A. |
| 18696555 | DENTAL COMPOSITION | Non-Final OA | GC Corporation |
| 17916215 | NANOFIBER-ENABLED ENCAPSULATION DEVICES AND USES THEREOF | Non-Final OA | CORNELL UNIVERSITY |
| 18744338 | METHOD FOR AMPLIFYING EXPRESSION OF TRANSPORTER-RELATED GENE IN EPIDERMAL CELLS | Non-Final OA | J-Network, Inc. |
| 18222825 | INTRACRANIAL DRUG DELIVERY MATERIALS AND METHODS | Final Rejection | Biotronik AG |
| 18018027 | MICROSPHERE DRUG COATED MEDICAL DEVICES, MATERIALS AND METHODS | Non-Final OA | BIOTRONIK AG |
| 18139125 | MEDICAL DEVICE COATINGS WITH MICROCRYSTALLINE ACTIVE AGENTS | Final Rejection | Surmodics, Inc. |
| 18034561 | BIOCOMPATIBLE MATERIAL AND METHOD OF PRODUCING SAME | Final Rejection | Maruemu Works Co., LTD. |
| 18683932 | STABLE CYCLOSPORINE OPHTHALMIC FORMULATION AND MANUFACTURING PROCESS THEREOF | Non-Final OA | SUN PHARMACEUTICAL INDUSTRIES LIMITED |
| 17756859 | STABILIZED DRUG FORMULATIONS AND METHODS OF LOADING DRUG DELIVERY IMPLANTS | Final Rejection | THE METHODIST HOSPITAL SYSTEM |
| 17906433 | IMPLANTABLE CELL CHAMBER DEVICE AND USES THEREOF | Non-Final OA | Takeda Pharmaceutical Company Limited |
| 18563595 | FLUID COSMETIC COMPOSITIONS WITH UNUSUAL RHEOLOGIC CHARACTERISTICS, POLYMERS ADAPTED TO PROVIDE THE ABOVE SAID CHARACTERISTICS AND THEIR SYNTHESIS | Non-Final OA | INTERCOS S.p.A. |
| 17156167 | NEURONAL AGONISTS AND ISOTONIC OR HYPERTONIC SALINE FOR TREATING RESPIRATORY DISEASES | Non-Final OA | University of Saskatchewan |
| 18560449 | A WATER-SOLUBLE GLASS RUMEN BOLUS | Non-Final OA | BIMEDA ANIMAL HEALTH LIMITED |
| 18270852 | AURICULAR RECONSTRUCTION USING 3D PRINTED AUTOLOGOUS CARTILAGE TISSUE | Non-Final OA | Tel HaShomer Medical Research Infrastructure and Services Ltd. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy